{"id":"W2890365096","doi":"10.1200/jco.2017.35.15_suppl.9085","title":"Updated safety and clinical activity of durvalumab monotherapy in previously treated patients with stage IIIB/IV NSCLC.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Durvalumab; Medicine; Internal medicine; Pneumonitis; Adverse effect; Rash; Gastroenterology; Clinical endpoint; Nausea; Oncology; Surgery; Nivolumab; Clinical trial; Cancer; Lung; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001285479,0.0002581452,0.0005656586,0.0002909745,0.0001338454,0.0005637613,0.0003337198,0.0002505119,0.001045929],"category_scores_gemma":[0.001206664,0.0001407432,0.0004695238,0.0003480708,0.0001139491,0.0003011241,0.0001572262,0.0005277683,0.0002501841],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007545947,"about_ca_system_score_gemma":0.0004027293,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001050334,"about_ca_topic_score_gemma":0.002661328,"domain_scores_codex":[0.9995251,0.0001519125,0.00005346914,0.00005902424,0.0001799738,0.00003057853],"domain_scores_gemma":[0.9991598,0.0001816776,0.000414784,0.00005802104,0.000109451,0.0000762739],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.06717741,0.001937184,0.2718048,0.001512358,0.00320751,0.0006999349,0.0002878258,0.003447093,0.08832603,0.0002993757,0.009955716,0.5513449],"study_design_scores_gemma":[0.01166875,0.05142187,0.8544169,0.000174602,0.003601083,0.004382911,0.00006952238,0.005376711,0.02778749,0.0002433364,0.04080148,0.00005526086],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9775556,0.01291642,0.0008270632,0.0003272217,0.00004034197,0.000189463,0.0036902,0.0001303481,0.004323265],"genre_scores_gemma":[0.9881098,0.002121468,0.001018391,0.0003208545,0.00006343544,0.0000945097,0.007150504,0.00001695368,0.001104082],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001285479,"threshold_uncertainty_score":0.006798327,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07735938050308919,"score_gpt":0.4521746059254099,"score_spread":0.3748152254223207,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}